California Eye Specialists | Pasadena, CA

Research site
2619 E Colorado Boulevard Suite 150, Pasadena, California, United States of America
Site insights

Top conditions

Geographic Atrophy (2 trials)

Macular Degeneration (2 trials)

Edema (1 trial)

Neoplasm Metastasis (1 trial)

Cerebral Amyloid Angiopathy (1 trial)

Top treatments


Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


4 of 5
Status: Active
Trial type: Interventional
Funder type: Industry

A Study of AMDX-2011P in Participants With CAA

The purpose of this study is to assess safety, tolerability, plasma pharmacokinetics and biologic activity of a single intravenous dose of AMDX-2011P...

Cerebral Amyloid Angiopathy
Drug: AMDX-2011P

Researchers are looking for a better way to treat people who have macular edema secondary to retinal vein occlusion (RVO).In people with RVO, a blood...

Macular Edema Secondary to Retinal Vein Occlusion
Drug: Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose
Diagnostic Test: Fluorescein

The objective of this study is to determine the safety and effectiveness of the smaller incision, new generation (SING), implantable miniature telesc...

Age-Related Macular Degeneration
Geographic Atrophy
Device: smaller incision, new generation implantable miniature telescope (SING-IMT)

In this study researchers want to learn more about changes in visual acuity (clarity of vision) with a high dose treatment with Aflibercept (Eylea) i...

Active, not recruiting
Neovascular Age-Related Macular Degeneration
Drug: Aflibercept VEGF Trap-Eye (Eylea, BAY86-5321)
Drug: Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)

Trial sponsors

Bayer logo

Bayer (2 trials)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems